EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Secondary, Subgroup Analysis of Alcohol Cue‐Exposure Craving in Response to Pharmacological Inhibition of the Growth Hormone Secretagogue Receptor With PF ‐5190457

Ryan E Tyler, Valerie Espinal Abreu, Mehdi Farokhnia iD, Lorenzo Leggio iD

Alcohol, Clinical and Experimental Research · 2026

DOI: 10.1111/acer.70366 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Ryan E Tyler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, NIDA Intramural Research Program and …. Hauptthemen laut MEDLINE: Craving, Cues, Receptors, Ghrelin, Alcoholism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ghrelin is the endogenous agonist of the growth hormone secretagogue receptor (GHSR), which is a potential novel pharmacotherapeutic target for alcohol use disorder (AUD). PF‐5190457 is a GHSR inverse agonist and the first GHSR inhibitor to advance to human trials. Our lab conducted two placebo‐controlled human laboratory studies to investigate the effects of PF‐5190457 (100 mg/day) on alcohol craving in an alcohol cue‐exposure paradigm. Study 1 found reduced craving under drug versus placebo, whereas Study 2 did not replicate these findings, likely due to a floor effect and reflective of the differences in AUD populations (Study 1: active drinkers; Study 2: abstinent, inpatient).

Methods

The present work is a secondary analysis combining these datasets and using subgroups based on alcohol cue‐reactivity (“cue‐reactors,” CR + vs. “nonreactors,” CR − ) or the Penn Alcohol Craving Scale (“PACS high cravers” vs. “PACS low cravers”) as an additional independent variable to reanalyze the effects of PF‐5190457 on alcohol craving (Alcohol Urge Questionnaire [AUQ]) following a “relaxation” trial (no cues) and an “alcohol cue” trial (mock bar‐lab and preferred alcohol‐containing drink). Cue‐reactivity was calculated as the difference in AUQ between trials (AUQ Alc ‐AUQ Rel ) and analyzed by subgroups as a separate outcome.

Results

PF‐5190457 reduced AUQ scores relative to placebo following the alcohol cue trial in the CR + subgroup, but not the CR − subgroup. PF‐5190457 also reduced AUQ compared to placebo following both the relaxation and alcohol cue trial in the PACS high craver subgroup, but not in the PACS low craver subgroup. Cue‐reactivity was not affected by PF‐5190457 in any subgroup analysis.

Conclusions

These results are preliminary and based on secondary analyses, but suggest that PF‐5190457 could help reduce general, self‐reported craving for alcohol in high‐craving individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CravingCuesReceptors, GhrelinAlcoholismSulfonamidesHumansMaleAdultFemaleMiddle AgedYoung AdultDouble-Blind MethodAlcohol DrinkingAzetidinesSpiro Compounds

Stichwörter der Autor:innen

PF‐5190457alcohol use disordercue‐reactivityghrelin

Substanzen

Receptors, GhrelinPF-5190457SulfonamidesAzetidinesSpiro Compounds

Autor:innen und Institutionen

  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, NIDA Intramural Research Program and NIAAA Division of Intramural Clinical and Biological Research, NIH, Ba…

ORCID-Profile: Mehdi Farokhnia, Lorenzo Leggio

Förderung

  • NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Center for Advancing Translational Sciences
  • National Institute of General Medical Sciences

Zitieren

APA

Tyler, R. E., Abreu, V. E., Farokhnia, M., & Leggio, L. (2026). A Secondary, Subgroup Analysis of Alcohol Cue‐Exposure Craving in Response to Pharmacological Inhibition of the Growth Hormone Secretagogue Receptor With PF ‐5190457. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70366

Vancouver

Tyler RE, Abreu VE, Farokhnia M, Leggio L. A Secondary, Subgroup Analysis of Alcohol Cue‐Exposure Craving in Response to Pharmacological Inhibition of the Growth Hormone Secretagogue Receptor With PF ‐5190457. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70366

BibTeX
@article{Tyler2026,
  author = {Tyler, Ryan E and Abreu, Valerie Espinal and Farokhnia, Mehdi and Leggio, Lorenzo},
  title = {A Secondary, Subgroup Analysis of Alcohol Cue‐Exposure Craving in Response to Pharmacological Inhibition of the Growth Hormone Secretagogue Receptor With PF ‐5190457},
  journal = {Alcohol, Clinical and Experimental Research},
  year = {2026},
  doi = {10.1111/acer.70366}
}
Kostenlos starten →